NAMS Announces $8B+ Peak Sales Potential for Obicetrapib, 45% Lp(a) Lowering, $729M Cash Position
NewAmsterdam Pharma Company N.V. Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $31.79
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS